CTMX vs POOL · rev $138.1M vs P/E 18, rev $5.31B
CytomX Therapeutics Inc (CTMX) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported CTMX revenue for 2024-12-31 was $138.1M. Net income was $31.9M. Revenue was up 36.4% from 2023-12-31 to 2024-12-31. CTMX currently screens at market cap $653.1M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
CTMX currently screens at market cap $653.1M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the CTMX and POOL stock pages for the full models.
Not investment advice.